RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 204.8 USD | +2.53% |
|
+5.18% | +19.07% |
| Jul. 01 | ResMed Inc.(NYSE:RMD) added to Russell 1000 Dynamic Index | CI |
| Jul. 01 | ResMed Inc.(NYSE:RMD) added to Russell Midcap Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-08-01
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
204.8
USD
Average target price
220.9
USD
Spread / Average Target
+7.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +19.07% | 30.09B | |
| +3.26% | 209B | |
| +6.55% | 183B | |
| +31.66% | 158B | |
| +34.32% | 114B | |
| +5.13% | 67.29B | |
| +19.33% | 54.83B | |
| -3.30% | 46.88B | |
| -4.84% | 38.58B | |
| +3.83% | 36.65B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- ResMed Fiscal Q3 Non-GAAP Earnings, Revenue Increase; Shares Rise After Hours
